A future for the world's children? A WHO–UNICEF–Lancet Commission - The Lancet
Addition of cetuximab to oxaliplatin-based first-line combination chemotherapy for treatment of advanced colorectal cancer: results of the randomised phase 3 MRC COIN trial - The Lancet